Moreover, EGFR expression has been shown to be required for progression of PanIN lesions to cancer in mice expressing K-ras mutations, under conditions of induction of pancreatitis by caerulein35; however, the manner by which EGFR signaling mediates this effect has not been described. The gene discussed is KRAS; the disease is cancer.